Statistics about Health, Pharma & Medtech in United States
Statistics
- Pacific Health Care net cash 2021-2025
- Aligos Therapeutics net cash 2021-2025
- Kura Oncology, Inc. net cash 2021-2025
- Alt5 Sigma Corp revenue 2021-2025
- Pepgen Inc. net cash 2021-2025
- Nutra Pharma Corp revenue 2021-2025
- Rigel Pharmaceuticals net income 2021-2025
- Sab Biotherapeutics, Inc. operating profit 2021-2025
- Ikena Oncology net income 2021-2025
- Cell Source net cash 2020-2024
- An2 Therapeutics total equity 2021-2025
- Nextcure total equity 2021-2025
- Niagen Bioscience, Inc. total equity 2021-2025
- American Shared Hospital operating profit 2021-2025
- Genelux total equity 2021-2025
- Nektar Therapeutics total equity 2021-2025
- Oragenics Inc net cash 2021-2025
- Genelux net cash 2022-2025
- Atara Biotherapeutics total equity 2021-2025
- Amylyx Pharmaceuticals operating profit 2021-2025
- Oncotelic Therapeutics, Inc. total equity 2021-2025
- Rani Therapeutics Holdings total equity 2021-2025
- Sunshine Biopharma Inc. gross profit 2021-2025
- Ani Pharmaceuticals operating profit 2021-2025
- Kala Bio net cash 2021-2025
- Oncocyte operating profit 2021-2025
- Nkarta operating profit 2021-2025
- Celularity Inc revenue 2021-2025
- Fulgent Genetics net cash 2021-2025
- Amylyx Pharmaceuticals net cash 2021-2025
- Cue Biopharma operating profit 2021-2025
- Cryoport revenue 2021-2025
- Agenus net cash 2021-2025
- Coherus Biosciences net cash 2021-2025
- Ligand Pharmaceuticals operating profit 2021-2025
- Nuvation Bio net cash 2021-2025
- Marpai operating profit 2021-2025
- Mannatech revenue 2021-2025
- Biomarin Pharmaceutical net cash 2021-2025
- Lftd Partners Inc. net cash 2021-2025
- Geron net cash 2021-2025
- Prelude Therapeutics net cash 2021-2025
- Kezar Life Sciences net cash 2021-2025
- Marimed Inc. operating profit 2021-2025
- Curis total equity 2021-2025
- Cabaletta Bio net cash 2021-2025
- Tevogen Bio Holdings Inc. total equity 2021-2025
- Bolt Biotherapeutics revenue 2021-2025
- Geron total equity 2021-2025
- Denali Therapeutics revenue 2021-2025
- Zyversa Therapeutics, Inc. net cash 2022-2025
- Pepgen Inc. operating profit 2021-2025
- Bolt Biotherapeutics net income 2021-2025
- Pyxis Oncology net income 2021-2025
- Context Therapeutics net cash 2021-2025
- Fortress Biotech total equity 2021-2025
- Aligos Therapeutics total equity 2021-2025
- Qualigen Therapeutics net income 2021-2025
- Fortress Biotech revenue 2021-2025
- Genprex, Inc operating profit 2021-2025
- Renovorx operating profit 2021-2025
- Pyxis Oncology total equity 2021-2025
- Marker Therapeutics net income 2021-2025
- Cyclerion Therapeutics total equity 2021-2025
- Bioxcel Therapeutics net cash 2021-2025
- Alt5 Sigma Corp operating profit 2021-2025
- Journey Medical revenue 2021-2025
- Zoetis total equity 2021-2025
- Zoetis net cash 2021-2025
- Xencor total equity 2021-2025
- Xencor liabilities 2021-2025
- Xencor net cash 2021-2025
- Xencor revenue 2021-2025
- Xencor operating profit 2021-2025
- Xencor net income 2021-2025
- Umbra Companies total equity 2021-2025
- Umbra Companies net cash 2021-2025
- Umbra Companies gross profit 2021-2025
- Umbra Companies operating profit 2021-2025
- Umbra Companies net income 2020-2025
- Umbra Companies revenue 2021-2025
- Agilon Health net cash 2021-2025
- Agilon Health operating profit 2021-2025
- Agilon Health revenue 2021-2025
- Agilon Health net income 2021-2025
- Viatris liabilities 2021-2025
- Vera Therapeutics total equity 2021-2025
- Viking Therapeutics net cash 2021-2025
- Viking Therapeutics total equity 2021-2025
- Viking Therapeutics liabilities 2021-2025
- Viking Therapeutics operating profit 2021-2025
- Viking Therapeutics net income 2021-2025
- Vir Biotechnology liabilities 2021-2025
- Vir Biotechnology revenue 2021-2025
- Vir Biotechnology net income 2021-2025
- Vericel total equity 2021-2025
- Vericel liabilities 2021-2025
- Vericel revenue 2021-2025
- Vericel operating profit 2021-2025
- Vericel gross profit 2021-2025